Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Inflammatory breast cancer]

B Chevallier1

  • 1Service d'oncologie médicale, centre régional de lutte contre le cancer Henri-Becquerel, Rouen, France.

Bulletin Du Cancer
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Inflammatory breast cancer (IBC) is a rare, aggressive cancer. Early chemotherapy improves survival, but further research is needed for better treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuum of care and survival in patients with metastatic colorectal cancer: results of the real-world prospective, longitudinal cohort PROMETCO study.

ESMO gastrointestinal oncology·2026
Same author

[Congenital thoracic deformities and 3D custom-made implants. New classification based on a series of 789 treated cases].

Annales de chirurgie plastique et esthetique·2022
Same author

Iatrogenic mediastinitis in bronchiolitis: Importance of avoiding pharyngeal aspiration.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2019
Same author

Non-typhi Salmonella enterica urinary tract infections.

Medecine et maladies infectieuses·2017
Same author

[Pediatricians-to-be: The imperative need of acquiring skills in adolescent in patient units].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2016
Same author

[Febrile ulceronecrotic Mucha-Habermann disease].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2015
Same journal

[Off-label use of venetoclax in myeloma].

Bulletin du cancer·2026
Same journal

[Cemiplimab - Adjuvant treatment for the cutaneous squamous cell carcinomas with high risk of relapse, operated and treated by radiotherapy].

Bulletin du cancer·2026
Same journal

Real-world outcomes and management of endometrial cancer in France from 2016 to 2021 (MOONBEAM study).

Bulletin du cancer·2026
Same journal

[Cardiotoxicity in children and adolescents with acute leukemia: Recommendations from the Leukemia Committee of the French Society of Childhood Cancer (SFCE)].

Bulletin du cancer·2026
Same journal

[Reirradiation: A new therapeutic paradigm in oncology].

Bulletin du cancer·2026
Same journal

[Robotics in oncological surgery].

Bulletin du cancer·2026
See all related articles

Area of Science:

  • Oncology
  • Medical Research

Context:

  • Inflammatory breast cancer (IBC) is a rare and aggressive form of breast cancer.
  • Diagnosis is primarily clinical, not requiring a positive skin biopsy.
  • Despite combined modality treatments, IBC often has a poor prognosis.

Purpose:

  • To review the current understanding and treatment approaches for inflammatory breast cancer.
  • To highlight the impact of induction chemotherapy on survival rates.
  • To identify areas for future research and therapeutic improvements.

Summary:

  • Induction chemotherapy prior to loco-regional treatment significantly improves 5-year overall survival in IBC.
  • Loco-regional treatment options include surgery or radiotherapy.
  • The efficacy of adjuvant chemotherapy requires further assessment through randomized trials.

Related Experiment Videos

Impact:

  • Current treatment strategies, particularly induction chemotherapy, have improved patient outcomes.
  • Future advancements may involve more intensive chemotherapy regimens or intensified adjuvant treatments.
  • The need for adequate randomized trials is crucial for advancing IBC treatment and improving patient survival.